Watchlist Price Alert

Mersana Therapeutics Inc. (MRSN)

NASDAQ: MRSN · Real-Time Price · USD

0.39

0.00 (1.06%)

At close: Jun 09, 2025, 3:59 PM

1.06% (1D)

Bid	0.38
Market Cap	49.08M
Revenue (ttm)	34.01M
Net Income (ttm)	-74.01M
EPS (ttm)	-0.59
PE Ratio (ttm)	-0.67
Forward PE	-0.63
Analyst	Buy

Ask	0.39
Volume	2,169,225
Avg. Volume (20D)	2,843,952
Open	0.38
Previous Close	0.39
Day's Range	0.38 - 0.40
52-Week Range	0.26 - 2.83
Beta	0.82

About MRSN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MRSN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

-17.24%

Mersana Therapeutics shares are trading lower afte... Unlock content with Pro Subscription

5 months ago

-44.62%

Mersana Therapeutics shares are trading lower. The company announced initial clinical data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin.

News

1 month ago · seekingalpha.com

Mersana Therapeutics, Inc. (MRSN) Q1 2025 Earnings Call Transcript

Mersana Therapeutics, Inc. (NASDAQ:MRSN ) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations & Corporate Communica...

1 month ago · zacks.com

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates

Mersana Therapeutics, Inc. (MRSN) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.16 per share a year ago.